Industrializing the next generation of cell and gene therapies
Our panel of experts discuss key challenges in industrial cell and gene therapy manufacturing, supply chain management & customer experience.Download now
Cell and gene therapies have had a tremendous effect on the treatment of previously incurable diseases. Many products are already on the road to commercialization.
However, scaling complex manufacturing operations is still a challenge and managing multiple concurrent workstreams is onerous and very manual. Each therapeutic developer needs to manage multiple factors/resources internally and externally to deliver a great customer and patient experience.
Watch our panel of experts discuss key challenges in industrial manufacturing, supply chain management, patient operations and order fulfilment. The panel of industry leaders also shares insights from their own experiences.
This webinar was made in partnership with Phacilitate.